688767.SS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 15:00):

Hangzhou Biotest Biotech Co., LTD. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and equipment in China and Internationally...

Stats
今日成交量	260 749
平均成交量	439 470
市值	2.71B
EPS	CNY0.280 ( 2023-09-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-141.17
ATR14	CNY0.0310 (0.12%)

音量相关性

長: -0.08 (neutral)

短: 0.36 (neutral)

Signal:(43.442) Neutral

Hangzhou Biotest Biotech 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Hangzhou Biotest Biotech 相关性 - 货币/商品

0.44
( neutral )

0.40
( neutral )

0.00
( neutral )

0.31
( neutral )

-0.31
( neutral )

0.36
( neutral )

Hangzhou Biotest Biotech 财务报表

Annual	2023
营收:	CNY442.36M
毛利润:	CNY442.36M (100.00 %)
EPS:	CNY1.040

FY	2023
营收:	CNY442.36M
毛利润:	CNY442.36M (100.00 %)
EPS:	CNY1.040

FY	2022
营收:	CNY1.90B
毛利润:	CNY1.02B (53.46 %)
EPS:	CNY7.25

FY	2021
营收:	CNY1.82B
毛利润:	CNY1.12B (61.83 %)
EPS:	CNY9.62

Financial Reports:

No articles found.

Hangzhou Biotest Biotech

Hangzhou Biotest Biotech Co., LTD. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and equipment in China and Internationally. It offers medical test products for fertility health, oncology, cardiology, inflammation, biochemistry, and various infectious diseases, as well as COVID-19 rapid tests, such as antibody and antigen testing kits; and urine and saliva drug, hair drug, and vitamin D rapid testing kits. The company also provides immunochromatography readers and fluorescence immunoassay quantitative analyzers. Hangzhou Biotest Biotech Co., LTD. was founded in 2008 and is based in Hangzhou, China.